Antonio Altamirano (@antonio) 's Twitter Profile
Antonio Altamirano

@antonio

Husband. Father. Builder of futures. I code, write, and dream with my eyes wide open.

ID: 11552

linkhttps://interesante.com calendar_today05-11-2006 23:04:27

2,2K Tweet

24,24K Followers

5,5K Following

a16z (@a16z) 's Twitter Profile Photo

Aaron Levie (Aaron Levie): “I’m seeing these 19 and 20 year olds… everybody’s dropping out.” Why? Because they can build at 100x. This new cohort moves with unprecedented velocity, collapsing cycles and rewriting what company building looks like in 2025.

The All-In Podcast (@theallinpod) 's Twitter Profile Photo

Jason Calacanis: Social media companies should disclose their algorithms or lose Section 230 protections Why? “An algorithm is more powerful than an editor at the New York Times or an editor at HBO or Netflix...” From E243: “Algorithms must be disclosed and you must have the

Haider. (@slow_developer) 's Twitter Profile Photo

OpenAI Chief Scientist, Jakub Pachocki: The long-term research goal is to develop an "automated researcher" capable of discovering new scientific ideas "current models can reason for 1-5 hours" The next frontier is long-term planning and memory

Andrew Yang🧢⬆️🇺🇸 (@andrewyang) 's Twitter Profile Photo

I personally think that a government shutdown would be tremendously damaging and should be avoided at all costs. The economy is in a delicate place and a shutdown would make it significantly worse.

Exec Sum (@exec_sum) 's Twitter Profile Photo

BREAKING: TikTok US to be valued at $14 Billion after Trump’s deal, White House says Oracle, private equity group Silver Lake, and Abu Dhabi’s MGX will control roughly 45% of TikTok US TikTok’s owner ByteDance will own 19.9%

BREAKING: TikTok US to be valued at $14 Billion after Trump’s deal, White House says

Oracle, private equity group Silver Lake, and Abu Dhabi’s MGX will control roughly 45% of TikTok US

TikTok’s owner ByteDance will own 19.9%
Antonio Altamirano (@antonio) 's Twitter Profile Photo

Is America actually making more money right now? The numbers say yes. 📈 GDP keeps climbing — the economy is bigger than last year. 💵 Federal revenue is up, topping nearly $5T. 👩‍👩‍👧‍👦 Household incomes are rising too. It’s not perfect — inflation and debt are real challenges —

Antonio Altamirano (@antonio) 's Twitter Profile Photo

America’s budget = culture remix Republicans: cut, cut, cut Democrats: protect the basics Trump: you’re fired Chaotic? Yeah. But that’s democracy’s beat — messy, loud, and still moving forward.

Antonio Altamirano (@antonio) 's Twitter Profile Photo

Trump doesn’t do half measures. It’s either silence… or full war. No middle gear. It’s ignore you or crush you Makes me wonder why Dems keep playing small

Antonio Altamirano (@antonio) 's Twitter Profile Photo

Visibility without leverage is vanity. Write your name only on the billboards that matter — the ones that decide who gets remembered.

Antonio Altamirano (@antonio) 's Twitter Profile Photo

The critics don’t matter. Symbols of freedom become chains when they aren’t backed by real programs. Gay, trans, immigrant rights — morally right, but used as shields by Democrats instead of being built into policies that actually serve. That gap is why the country’s psyche

Antonio Altamirano (@antonio) 's Twitter Profile Photo

Love this. One pulse to rule them all. Imagine it waking you up like: “Hey champ, you’ve been crushing it — but also, that magnesium you’re taking? Basically chalk. Switch it up.” That’s the assistant I need.

Naval (@naval) 's Twitter Profile Photo

AI is intelligent to the extent it can get you what you want. AGI is intelligent to the extent it can get itself what it wants.

VraserX e/acc (@vraserx) 's Twitter Profile Photo

Sam Altman is betting on a pill to rejuvenate the brain. - Retro Biosciences just launched human trials for RTR242 - The drug aims to slow Alzheimer’s and boost cellular recycling (autophagy) - If it works, it could become the first real “brain anti-aging” therapy Silicon

Sam Altman is betting on a pill to rejuvenate the brain.

- Retro Biosciences just launched human trials for RTR242
- The drug aims to slow Alzheimer’s and boost cellular recycling (autophagy)
- If it works, it could become the first real “brain anti-aging” therapy

Silicon
Sam Altman (@sama) 's Twitter Profile Photo

You can skip all the parties, all the conferences, all the press, all the tweets. Build a great product and get users and win.